Identification of a novel tumor suppressor gene on chromosome arm 18q in human pancreatic caner
人胰腺癌染色体臂 18q 上新型抑癌基因的鉴定
基本信息
- 批准号:18390118
- 负责人:
- 金额:$ 9.88万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Loss of 18q is highly frequent in human pancreatic cancer. A tumor suppressor gene, SMAD4, resides in this region, but introduction of this gene inhibit tumor cell growth only in vivo by means of angiogenesis inhibition through ETS. Introduction of chromosome 18, however, inhibit both in vitro and in vivo. Moreover, in most of the early lesions of the pancreatic tumorigeneses, 18q is lost but SMAD4 functions normally. Allelotype analyses on 18q identified a commonly lost region between D18S451 and D18S462. Database search indicated a total of 164 protein coding genes. One of such genes, PMAIP1, was picked up by the microarray analyses. This gene is frequently suppressed in pancreatic cancer. Upregulation of this gene caused suppression of the cell growth in pancreatic cancer cells. On the contrary, siRNA-mediated knockdown of the PMAIP1 stimulated cell growth. Thus, the PMAIP1 gene is one of the candidate tumor suppressor genes for pancreatic cancer.We further performed systematic knockdown studies using siRNAs for all the protein-coding genes in the commonly deleted region. Recovery of the cell growth was monitored and we picked up a total of 13 candidate genes. Further detailed studies are necessary.In the course of these studies, we developed a modified buffer system for ligation. Using this system, we can perform ligations in a cheap, efficient, and rapid manner. A total of 100 ligation reaction can be done within a 10 minutes only spending one dollar for 100 reactions. Thus, we named this method as "Coffee break ligation technique."
18q缺失在人类胰腺癌中非常常见。肿瘤抑制基因SMAD 4存在于该区域中,但该基因的引入仅通过ETS抑制血管生成而在体内抑制肿瘤细胞生长。然而,18号染色体的引入在体外和体内都具有抑制作用。此外,在大多数胰腺肿瘤发生的早期病变中,18q丢失,但SMAD 4功能正常。等位基因型分析18 q确定了一个常见的丢失区域之间的D18S451和D18S462。数据库检索表明,共有164个蛋白质编码基因。其中一个基因PMAIP1被微阵列分析挑出来。这种基因在胰腺癌中经常被抑制。该基因的上调导致胰腺癌细胞中细胞生长的抑制。相反,siRNA介导的PMAIP 1敲除刺激了细胞生长。因此,PMAIP 1基因是胰腺癌的候选抑癌基因之一。我们进一步使用siRNA对常见缺失区域的所有蛋白编码基因进行了系统的敲除研究。监测细胞生长的恢复,我们总共挑选了13个候选基因。在这些研究的过程中,我们开发了一种改良的连接缓冲系统。使用该系统,我们可以以廉价,高效和快速的方式进行连接。总共100个连接反应可以在10分钟内完成,100个反应仅花费1美元。因此,我们将这种方法命名为“咖啡休息结扎技术”。"
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Identification of SMURF1 as a possible target for 7q21. 3-22. 1 amplification detected in pancreatic cancer cell line by in-house array-based comparative genomic hybridization.
鉴定 SMURF1 作为 7q21 的可能靶标。
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Suzuki A;Shibata T;Shimada Y;Murakami Y;Horii A;Shiratori K;Hirohashi S;Inazawa J;Imoto I
- 通讯作者:Imoto I
Genetic diagnosis of pancreatic cancer using whole genome amphlification
利用全基因组扩增进行胰腺癌的基因诊断
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:阿部 忠義、堀井 明;他
- 通讯作者:他
Suppressed expression of FBXW7 and contrastive enhanced expression of positive cell cycle regulators human glioma.
人胶质瘤中 FBXW7 的表达受到抑制,而阳性细胞周期调节因子的表达则相反增强。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Gu Zhaodi、堀井 明;他
- 通讯作者:他
Elucidation of the relationship of BNIP3 expression to gemcitabine chemosensitivity and prognosis
- DOI:10.3748/wjg.v13.i34.4593
- 发表时间:2007-09-14
- 期刊:
- 影响因子:4.3
- 作者:Ishida, Masaharu;Sunamura, Makoto;Horii, Akira
- 通讯作者:Horii, Akira
Genetic diagnosis for pancreatic cancer
胰腺癌的基因诊断
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Aoki;R.;Yagami;T.;Miyamae;T.;Nakamura;F.;Ogura;K.;Kajiwara;Y.;Yamamoto;N.;Sasakura;H.;Mori;I.;Goshima;Y;Horii A.
- 通讯作者:Horii A.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HORII Akira其他文献
HORII Akira的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HORII Akira', 18)}}的其他基金
Development of invasion and/or metastasis of pancreatic and lung cancers by controlling S100A4
通过控制S100A4促进胰腺癌和肺癌的侵袭和/或转移
- 批准号:
23590452 - 财政年份:2011
- 资助金额:
$ 9.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
New avenue for molecular diagnosis of pancreatic and gynecological cancers
胰腺癌和妇科癌症分子诊断的新途径
- 批准号:
17015003 - 财政年份:2005
- 资助金额:
$ 9.88万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Reseearch on Genetic Alterations in the Development and Progression of Human Pancreatic Cancer
人类胰腺癌发生发展中的基因改变研究
- 批准号:
12470043 - 财政年份:2000
- 资助金额:
$ 9.88万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Genetic alterations involved in initiation and progression of human cancer
基因改变参与人类癌症的发生和进展
- 批准号:
07272204 - 财政年份:1999
- 资助金额:
$ 9.88万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Towards establishment of gene therapy for human pancreatic and endometrial cancers
建立人类胰腺癌和子宫内膜癌的基因疗法
- 批准号:
10557026 - 财政年份:1998
- 资助金额:
$ 9.88万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Genetic alterations involved in initiation and progression of human pancreatic cancer
基因改变参与人类胰腺癌的发生和进展
- 批准号:
09470049 - 财政年份:1997
- 资助金额:
$ 9.88万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identification of tumor suppressor genes in human pancreatic cancer
人胰腺癌抑癌基因的鉴定
- 批准号:
07457046 - 财政年份:1995
- 资助金额:
$ 9.88万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
網羅的なCpG siteのDNAメチル化の検索による肺腺癌のtumor suppressor geneの同定
综合寻找CpG位点DNA甲基化鉴定肺腺癌抑癌基因
- 批准号:
23K08296 - 财政年份:2023
- 资助金额:
$ 9.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Modeling Breast Cancer Associated with KMT2C as a Haploinsufficient and Recessive Tumor Suppressor Gene
与作为单倍体不足和隐性肿瘤抑制基因 KMT2C 相关的乳腺癌建模
- 批准号:
491638 - 财政年份:2023
- 资助金额:
$ 9.88万 - 项目类别:
Miscellaneous Programs
Enhancer RNA-mediated Tumor Suppressor Gene Expression in Normal and Malignant Hematopoiesis
正常和恶性造血过程中增强 RNA 介导的肿瘤抑制基因表达
- 批准号:
10755937 - 财政年份:2022
- 资助金额:
$ 9.88万 - 项目类别:
Comprehensive modeling of tumor suppressor gene-derived neoantigens in pancreatic cancer
胰腺癌中抑癌基因衍生的新抗原的综合建模
- 批准号:
10389366 - 财政年份:2022
- 资助金额:
$ 9.88万 - 项目类别:
SNF2 Histone Linker PHD RING Helicase as a novel tumor suppressor gene and risk factor in lung adenocarcinoma development
SNF2 组蛋白连接器 PHD RING 解旋酶作为新型抑癌基因和肺腺癌发展的危险因素
- 批准号:
472467 - 财政年份:2022
- 资助金额:
$ 9.88万 - 项目类别:
Operating Grants
Investigation of therapeutic targets in KRAS-mutant lung cancer cells co-existing multiple tumor suppressor gene mutations
共存多种抑癌基因突变的 KRAS 突变肺癌细胞治疗靶点的研究
- 批准号:
21K20793 - 财政年份:2021
- 资助金额:
$ 9.88万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Mechanism of neuroendocrine tumor suppression by the tumor suppressor gene PHLDA3
抑癌基因PHLDA3抑制神经内分泌肿瘤的机制
- 批准号:
20H03523 - 财政年份:2020
- 资助金额:
$ 9.88万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The Single Cell Biology of Context-Specific Responses to Loss of the RB Tumor Suppressor Gene
对 RB 肿瘤抑制基因丢失的特定反应的单细胞生物学
- 批准号:
419746 - 财政年份:2020
- 资助金额:
$ 9.88万 - 项目类别:
Operating Grants
3'UTR-dependent regulation of the PTEN tumor suppressor gene
PTEN 肿瘤抑制基因的 3UTR 依赖性调节
- 批准号:
10212969 - 财政年份:2020
- 资助金额:
$ 9.88万 - 项目类别:
Investigating Max as a tumor suppressor gene in small cell lung cancer and other neuroendocrine tumors
研究 Max 作为小细胞肺癌和其他神经内分泌肿瘤的抑癌基因
- 批准号:
10662195 - 财政年份:2020
- 资助金额:
$ 9.88万 - 项目类别:














{{item.name}}会员




